NVIDIA, Rubicon Project, NeoPhotonics News Today

Valeant Pharmaceuticals Intl Inc (VRX), DSW Inc. (DSW), and Kandi Technologies Group Inc (KNDI) are in the news today

Mar 15, 2017 at 10:07 AM
facebook twitter linkedin


U.S. stocks are gaining this morning, ahead of this afternoon's Fed decision. Meanwhile, among specific names in focus are semiconductor stock NVIDIA Corporation (NASDAQ:NVDA), tech firm The Rubicon Project Inc (NYSE:RUBI), and circuit maker NeoPhotonics Corp (NYSE:NPTN). Here's a quick roundup of the headlines moving shares of NVDA, RUBI, and NPTN.

NVIDIA Stock Dips Despite Bosch News

NVDA is down 0.2% at $101.65, giving up early gains stemming from reports the company is working with Bosch (subscription required) to combine artificial intelligence with the industrial company's self-driving technology. While NVIDIA Corporation stock has returned to triple-digit territory, it still remains well below its all-time high of $120.92, and is now struggling to retake its 80-day moving average. Still, short-term options traders are unusually call-skewed, with NVDA boasting a Schaeffer's put/call open interest ratio (SOIR) of 0.89 -- just 8 percentage points from a 12-month high.

The Rubicon Project Falls Hard After Earnings

RUBI is getting crushed this morning, following the company's quarterly earnings report, and news the firm hired a new CEO. A number of analysts were quick to respond, including downgrades from Craig Hallum and B.Riley, who both gave the stock the equivalent of a "hold" rating. RBC, meanwhile, cut its price target by more than 41% to $7 from $12. The stock is down 24% today at $6.38, bringing its 12-month loss to 60%. Most analysts were already in the bears' corner, with just three of 11 brokerage firms doling out "buy" or better opinions. 

NeoPhotonics Forecast Spooks Wall Street

NPTN is also selling off after earnings, last seen down 11.4% at $7.16, earlier hitting an annual low of $6.90. Most concerning was the company's current-quarter outlook, which came in well below estimates. In response, no fewer than four brokerage firms cut their price targets, with the lowest mark coming from B. Riley, at $8. NeoPhotonics Corp stock has been sliding on the charts since its September high of $18.51, yet most analysts remain bullish. Specifically, five of six brokerage firms rate NPTN stock a "strong buy," with no "sell" ratings on the books. 

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.

Winning With Weekly Options

1606854690

  


 
Special Offers from Schaeffer's Trading Partners